These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9368923)

  • 1. Quality of life as an outcome measure for epilepsy clinical trials.
    Cramer JA
    Pharm World Sci; 1997 Oct; 19(5):227-30. PubMed ID: 9368923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
    Rahman Z; Wong CH; Dexter M; Olsson G; Wong M; Gebsky V; Nahar N; Wood A; Byth K; King M; Bleasel AB
    Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.
    Luoni C; Bisulli F; Canevini MP; De Sarro G; Fattore C; Galimberti CA; Gatti G; La Neve A; Muscas G; Specchio LM; Striano S; Perucca E;
    Epilepsia; 2011 Dec; 52(12):2181-91. PubMed ID: 22136077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy.
    Kline Leidy N; Rentz AM; Grace EM
    Epilepsia; 1998 Sep; 39(9):965-77. PubMed ID: 9738676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency.
    Feldman L; Lapin B; Busch RM; Bautista JF
    Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizure reduction and quality of life improvements in people with epilepsy.
    Birbeck GL; Hays RD; Cui X; Vickrey BG
    Epilepsia; 2002 May; 43(5):535-8. PubMed ID: 12027916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.
    Meschede C; Witt JA; Rademacher M; von Wrede RD; Elger CE; Helmstaedter C
    Seizure; 2018 May; 58():141-146. PubMed ID: 29704679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the impact of memory and mood on antiepileptic drug adherence.
    McAuley JW; Passen N; Prusa C; Dixon J; Cotterman-Hart S; Shneker BF
    Epilepsy Behav; 2015 Feb; 43():61-5. PubMed ID: 25561379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of life and cost-effect aspects of epilepsy pharmacotherapy of women].
    Iutskova EV; Avakian GN; Tatarinova MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):52-5. PubMed ID: 17310798
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
    Connock M; Frew E; Evans BW; Bryan S; Cummins C; Fry-Smith A; Li Wan Po A; Sandercock J
    Health Technol Assess; 2006 Mar; 10(7):iii, ix-118. PubMed ID: 16545206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
    Lutz MT; Helmstaedter C
    Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognition and health-related quality of life in a well-defined subgroup of patients with partial epilepsy.
    Engelberts NH; Klein M; van der Ploeg HM; Heimans JJ; Adèr HJ; van Boxtel MP; Jolles J; Kasteleijn-Nolst Trenité DG
    J Neurol; 2002 Mar; 249(3):294-9. PubMed ID: 11993529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of components included in published societal perspective or QALY outcome economic analyses for antiepileptic drug treatment in chronic epilepsy.
    Roberts MH; Takeda MY; Kindilien S; Barqawi YK; Borrego ME
    Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):487-503. PubMed ID: 29911955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trial.
    Jacoby A; Sudell M; Tudur Smith C; Crossley J; Marson AG; Baker GA;
    Epilepsia; 2015 Mar; 56(3):460-72. PubMed ID: 25630353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic drug-related cognitive complaints in seizure-free children with epilepsy before and after drug discontinuation.
    Aldenkamp AP; Alpherts WC; Sandstedt P; Blennow G; Elmqvist D; Heijbel J; Nilsson HL; Tonnby B; Wåhlander L; Wosse E
    Epilepsia; 1998 Oct; 39(10):1070-4. PubMed ID: 9776327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countries.
    Heaney DC; Shorvon SD; Sander JW; Boon P; Komarek V; Marusic P; Dravet C; Perucca E; Majkowski J; Lima JL; Arroyo S; Tomson T; Ried S; van Donselaar C; Eskazan E; Peeters P; Carita P; Tjong-a-Hung I; Myon E; Taieb C
    Epilepsia; 2000; 41 Suppl 5():S37-44. PubMed ID: 11045437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of adverse events and quality of life in epilepsy: design of a new community-based trial.
    Privitera M; Ficker DM
    Epilepsy Behav; 2004 Dec; 5(6):841-6. PubMed ID: 15582830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and memory effects of the new antiepileptic drugs.
    Meador KJ
    Epilepsy Res; 2006 Jan; 68(1):63-7. PubMed ID: 16377148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.